Patents by Inventor Sabine Heer

Sabine Heer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of loteprednol and ?-adrenoceptor agonists
    Patent number: 7521438
    Abstract: The invention relates to a novel combination of a soft steroid, in particular loteprednol, and at least one ?2 adrenoceptor agonist for the simultaneous, sequential or separate treatment of allergies and/or airway disorders, medicaments comprising the combination, processes for the production of such medicaments and the use of the novel combination for the production of medicaments for the simultaneous, sequential or separate treatment of allergies and/or airway disorders.
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: April 21, 2009
    Assignee: MEDA Pharma GmbH & Co. KG
    Inventors: Istvan Szelenyi, Hildegard Kuss, Sabine Heer, Juergen Engel
  • Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Patent number: 7161009
    Abstract: The invention relates to new hydroxyindoles of the Formula, their use as inhibitors of phosphodiesterase 4 and processes for their preparation.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: January 9, 2007
    Assignee: Elbion AG
    Inventors: Norbert Höfgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelényi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • Combination of loteprednol and antihistamines
    Patent number: 7022687
    Abstract: The present invention relates to a novel combination of a soft steroid, in particular loteprednol, and at least one antihistamine, such as, for example, azelastine and/or levocabastine, for simultaneous, sequential or separate administration in the local treatment of allergies and airway disorders, for example of allergic rhinitis (rhinoconjunctivitis).
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: April 4, 2006
    Assignee: Asta Medica AG
    Inventors: Istvan Szelenyl, Degenhard Marx, Sabine Heer, Juergen Engel
  • Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Publication number: 20040220183
    Abstract: The invention relates to new hydroxyindoles of the Formula, 1
    Type: Application
    Filed: May 27, 2004
    Publication date: November 4, 2004
    Inventors: Norbert Hofgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelenyi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Patent number: 6613794
    Abstract: The invention relates to new hydroxyindoles of the Formula, their use as inhibitors of phosphodiesterase 4 and processes for their preparation.
    Type: Grant
    Filed: January 20, 2003
    Date of Patent: September 2, 2003
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Norbert Höfgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelényi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Patent number: 6602890
    Abstract: The invention relates to new hydroxyindoles of the Formula, their use as inhibitors of phosphodiesterase 4 and processes for their preparation.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: August 5, 2003
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Norbert Höfgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelényi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Publication number: 20030134876
    Abstract: The invention relates to new hydroxyindoles of the Formula, 1
    Type: Application
    Filed: January 20, 2003
    Publication date: July 17, 2003
    Inventors: Norbert Hofgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelenyi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Patent number: 6545158
    Abstract: The invention relates to new hydroxyindoles of the Formula, their use as inhibitors of phosphodiesterase 4 and processes for their preparation.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: April 8, 2003
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Norbert Höfgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelényi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Patent number: 6545025
    Abstract: The invention relates to nets hydroxyindoles of the Formula, their use as inhibitors of phosphodiesterase 4 and processes for their preparation.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: April 8, 2003
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Norbert Höfgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelényi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Publication number: 20020137745
    Abstract: The invention relates to new hydroxyindoles of the Formula, 1
    Type: Application
    Filed: February 21, 2002
    Publication date: September 26, 2002
    Inventors: Norbert Hofgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelenyi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Publication number: 20020119971
    Abstract: The invention relates to new hydroxyindoles of the Formula, 1
    Type: Application
    Filed: February 21, 2002
    Publication date: August 29, 2002
    Inventors: Norbert Hofgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelenyi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Publication number: 20020115651
    Abstract: The invention relates to new hydroxyindoles of the Formula, 1
    Type: Application
    Filed: February 21, 2002
    Publication date: August 22, 2002
    Inventors: Norbert Hofgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelenyi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
    Publication number: 20020111351
    Abstract: The invention relates to nets hydroxyindoles of the Formula, 1
    Type: Application
    Filed: February 21, 2002
    Publication date: August 15, 2002
    Inventors: Norbert Hofgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelenyi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation
    Patent number: 6251923
    Abstract: The invention relates to new hydroxyindoles of the Formula, their use as inhibitors of phosphodiesterase 4 and processes for their preparation.
    Type: Grant
    Filed: April 28, 1999
    Date of Patent: June 26, 2001
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Norbert Höfgen, Ute Egerland, Hildegard Poppe, Degenhard Marx, Stefan Szelényi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer
  • 3-cyano-5,4'-bipyridine-1'-oxide compounds and pharmaceutical compositions and methods containing the same
    Patent number: 5162533
    Abstract: A 3-cyano-5,4'-bipyridine-1'-oxide of the formula ##STR1## and their pharmaceutically acceptable acid addition salts, wherein R is an amino, alkoxy, oxyalkoxy or chloro residue, have heart stimulating cardiotonic and vasodiolatory properties. They can be preparaed by (a) converting an R-substituted-3-cyano-bipyridine to its corresponding N-oxide, or (b) by substituting an R-residue or an R-unsubstituted precursor of the conpound of fomula (i), and if required, converting the product into its pharmaceutically acceptable acid addition salt.
    Type: Grant
    Filed: March 7, 1991
    Date of Patent: November 10, 1992
    Assignee: Arzneimittelwerk Dresden G.m.b.H.
    Inventors: Erhard Klauschenz, Volker Hagen, Angela Hagen, Peter Muschick, Brigitte Schlegel, Sabine Heer, Gottfried Faust, Hans-Joachim Jansch
  • Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation
    Patent number: RE38624
    Abstract: The invention relates to new hydroxyindoles of the Formula, their use as inhibitors of phosphodiesterase 4 and processes for their preparation.
    Type: Grant
    Filed: September 19, 2002
    Date of Patent: October 12, 2004
    Assignee: Elbion AG
    Inventors: Norbert Hofgen, Ute Egerland, Hildegard Kuss, Degenhard Marx, Stefan Szelenyi, Thomas Kronbach, Emmanuel Polymeropoulos, Sabine Heer